OSE Immunotherapeutics SA has appointed Gérard Tardy as a director and chairman of the board of directors following the resignation of Emile Loria, a founder of the company. Mr Tardy is a healthcare investor having managed two private equity funds in Paris. In 1999 he formed his own investment group Sitka Ltd in London. He is currently a member of the investment committee of Mérieux Développement. Mr Tardy is a graduate of the HEC Paris business school.
OSE Immunotherapeutics announced the appointment on 3 January 2018.
Copyright 2018 Evernow Publishing Ltd